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Abstract
Background Hyperhomocysteinemia (hyper-Hcy) is an
important and reversible cardiovascular disease risk factor.
We examined the prevalence of hyper-Hcy, plasma folate
levels, and dietary folate intake in adolescents and young
adults who had undergone kidney transplantation during
childhood to assess the necessity for managing dietary
folate.
Methods This cross-sectional study was performed in 89
kidney transplant recipients (age at kidney transplantation:
12.6 ± 4.1 years; age during study: 21.2 ± 5.5 years).
Hyper-Hcy and plasma folate deficiency were defined as
plasma homocysteine (Hcy) [15 nmol/ml and plasma
folate \3.0 ng/ml, respectively.
Results Of the patients, 60 (67.4 %) had hyper-Hcy and
14 (15.7 %) had plasma folate deficiency. Plasma homo-
cysteine levels correlated negatively with estimated glo-
merular filtration rate (eGFR; r = -0.565, p \ 0.01) and
plasma folate levels (r = -0.434, p \ 0.01). For deter-
minants of plasma homocysteine levels, a priori selected
variables included kind of calcineurin inhibitor, age at
kidney transplantation, pretransplant duration of dialysis,
time since transplantation, age at examination, eGFR, and
plasma folate. Stepwise multiple linear regression analysis
revealed eGFR and plasma folate levels as significant
independent variables influencing plasma homocysteine
levels. Dietary folate intake in 11 of 16 patients (66.8 %)
with eGFR C60 ml/min/1.73 m2 was below the recom-
mended dietary allowance for Japanese.
Conclusions The prevalence of hyper-Hcy and plasma
folate deficiency, as well as the low dietary folate intake,
suggest that dietary management of folate is necessary for
adolescents and young adults who have undergone kidney
transplantation during childhood.
Keywords Pediatric kidney transplantation  Adolescent
and young adult kidney transplant recipients 
Homocysteine  Folate  Dietary management
Introduction
Cardiovascular disease (CVD) is common in kidney
transplant recipients [1]. Similar to in adults, CVD mor-
bidity and mortality in pediatric kidney transplant recipi-
ents are higher than in the general population [2].
Therefore, primary prevention and treatment of CVD are
considerations for the management of kidney transplant
recipients for long-term survival following transplantation.
CVD morbidity and mortality are caused by the presence of
traditional risk factors, such as hypertension, dyslipidemia,
and diabetes mellitus, and are compounded by several
nontraditional risk factors, such as calcium-phosphate
metabolism, hyperparathyroidism, and inflammation [2].
Hyperhomocysteinemia (hyper-Hcy) has been identified as
an important and reversible CVD risk factor [3] that is
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commonly found in chronic kidney disease (CKD) patients
[4]. In hyper-Hcy, plasma homocysteine levels tend to
increase in line with decreasing glomerular filtration rate
(GFR) [5]. In addition to kidney dysfunction, folate intake
can also influence plasma homocysteine levels [4].
The prevalence of hyper-Hcy and the relationship
between plasma homocysteine and plasma folate levels are
well known in adult kidney transplant recipients [6].
However, little is known on this relationship in adolescents
and young adults who have undergone kidney transplant as
a child [7]. Moreover, there are few reports of dietary folate
intake in kidney transplant recipients of any age. Therefore,
we examined the prevalence of hyper-Hcy, plasma folate
levels, and dietary folate intake in adolescents and young
adults who had undergone kidney transplantation during
childhood to assess the necessity for managing dietary
folate.
Patients and methods
Patients and plasma samples
The study was approved by the ethics committee of the
School of Medicine at Tokyo Women’s Medical University
(approval number 2445). This cross-sectional study was
performed in 89 adolescent and young adult recipients who
had undergone kidney transplantation during childhood.
No patients were on folic acid supplementation before and
during the data collection period (October to November,
2009). Patient data included age at the time of the study,
sex, primary disease, transplant characteristics, donor dif-
ference (living or cadaver), preemptive kidney transplan-
tation (PEKT) or nonpreemptive kidney transplantation
(non-PEKT), pretransplant duration of dialysis, age at
kidney transplantation, time since transplantation, and
frequency of calcineurin inhibitor (tacrolimus or cyclo-
sporine) use.
The estimated glomerular filtration rate (eGFR) of
young adults was calculated using the Japanese equation
for estimating GFR [8], while the eGFR of adolescents was
assessed according to Schwartz’s formula [9]. Plasma
homocysteine was measured by high-performance liquid
chromatography [10], and plasma folate was measured by
chemiluminescent enzyme immunoassay (CLEIA) [11].
Both procedures were conducted by SRL, Inc. (Tokyo,
Japan).
eGFR level was defined as follows: normal, C90
ml/min/1.73 m2; mild decreased, C60 and \90 ml/min/
1.73 m2; and moderate to severe decreased, \60 ml/min/
1.73 m2 [12]. Hyper-Hcy was defined as homocysteine
[15 nmol/ml [13]. Plasma folate deficiency was defined as
plasma folate \3.0 ng/ml [14].
Dietary folate intake
Dietary folate intake was measured using the food frequency
questionnaires (FFQg) method [15] that included 29 food
groups and 10 kinds of cooking methods. The questionnaire
was designed to estimate the energy and nutrient intake of the
respondent during the previous 1–2 months. The reproduc-
ibility and validity of this method are well accepted [15]. The
recommended dietary allowance (RDA) of folate is 240
lg/day [16], and the RDA was used to evaluate whether or not
the dietary folate intake of patients was sufficient.
Statistical analysis
Statistical analysis was performed using SPSS version 12.0
(SPSS Inc., Chicago, IL, USA). Data are presented as
mean ± standard deviation (SD), median, and range val-
ues. The Kolmogorov–Smirnov test was used to test nor-
mality, and logarithmic transformations were made for all
variables, if needed. Spearman’s rank correlation coeffi-
cients were used to analyze the association between plasma
homocysteine and eGFR or plasma folate levels. Stepwise
multiple linear regression models were used to examine the
determinants of plasma homocysteine levels. The statistical
difference of dietary folate intake between the two groups
was determined using the Mann–Whitney U test. Signifi-
cance was set at p \ 0.05.
Results
Clinical characteristics of patients
Adolescents and young adults [n = 89; male, n = 48
(53.9 %)] who had undergone kidney transplantation during
childhood were examined. Clinical characteristics of patients
are presented in Table 1. Congenital anomalies of the kidney
and urinary tract (CAKUT) was the most common primary
disease (47.2 %), and living kidney donors constituted 84.3 %
(n = 75). Patients who had received kidney transplantation
after dialysis accounted for 78.7 % of subjects, and the mean
pretransplant duration of dialysis was 3.1 ± 2.5 years. The
mean age at kidney transplantation was 12.6 ± 4.1 years, and
the mean time since transplantation was 9.0 ± 5.7 years. The
frequency of tacrolimus use was 75.3 %. The mean age at the
time of the study was 21.2 ± 5.5 years, and the mean eGFR of
patients was 55.5 ± 19.9 ml/min/1.73 m2.
Plasma homocysteine distribution
The distribution of plasma homocysteine levels
(7.2–69.3 nmol/ml, mean 20.8 ± 12.1 nmol/ml) is shown
in Fig. 1. Sixty patients (67.4 %) had hyper-Hcy.
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Plasma folate distribution
The distribution of plasma folate levels (1.9–15.2 ng/ml,
mean 4.8 ± 2.3 ng/ml) is shown in Fig. 2. Fourteen
patients (15.7 %) had plasma folate deficiency.
Plasma homocysteine and eGFR
Plasma homocysteine levels correlated negatively with
eGFR (r = -0.565, p \ 0.01) (Fig. 3).
Plasma homocysteine and plasma folate
Plasma homocysteine levels correlated negatively with
plasma folate levels (r = -0.434, p \ 0.01) (Fig. 4).
Determinants of plasma homocysteine
For determinants of plasma homocysteine levels, a priori
selected variables included kind of calcineurin inhibitor
Table 1 Characteristics of kidney transplant recipients (n = 89)
Variable n (%) or
mean ± SD
Median Range
Gender
Male 48 (53.9)
Female 41 (46.1)
Primary disease
CAKUT 42 (47.2)
FSGS 16 (18.0)
GN 14 (15.7)
CNS 2 (2.2)
Others 15 (16.9)
Kidney transplantation
Living kidney transplantation 75 (84.3)
Cadaver kidney transplantation 14 (15.7)
Preemptive transplantation 19 (21.3)
Nonpreemptive transplantation 70 (78.7)
Pretransplant duration of
dialysis (years)
3.1 ± 2.5 2.5 0.2–10.6
Age at transplantation (years) 12.6 ± 4.1 13 3.7–19.8
Years posttransplant (years) 9.0 ± 5.7 8.3 0.3–27.3
Calcineurin inhibitor
Tacrolimus 67 (75.3)
Cyclosporine 21 (23.6)
Patient characteristics examined at the study
Age (years) 21.2 ± 5.5 20 15–38
eGFR (ml/min/1.73 m2) 55.5 ± 19.9 55 8–102
eGFR C90 4 (4.5)
60 B eGFR \ 90 33 (58.4)
eGFR \ 60 52 (37.1)
Data presented as percentage, mean ± standard deviation (SD),
median, and range
BMI body mass index, eGFR estimated glomerular filtration rate,
CAKUT congenital anomalies of the kidney and urinary tract, GN
glomerulonephritis, FSGS focal segmental glomerulosclerosis, CNS
congenital nephrotic syndrome
Plasma homocysteine level (nmol/ml)
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Fig. 1 Plasma homocysteine (Hcy) levels. The dotted line indicates
the normal Hcy level (15.0 nmol/ml). Sixty of 89 patients (67.4 %)
had hyperhomocysteinemia (hyper-Hcy)
C
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Plasma folate level (ng/ml)
Fig. 2 Plasma folate levels. The dotted line indicates the normal
folate level (3.0 ng/ml). Fourteen of 89 patients (15.7 %) had plasma
folate deficiency
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(tacrolimus or cyclosporine), age at kidney transplantation,
pretransplant duration of dialysis, time since transplanta-
tion, age at examination, eGFR, and plasma folate. Step-
wise multiple linear regression analysis revealed eGFR
(b = -0.522, t = -6.521, p \ 0.001) and plasma folate
(b = -0.453, t = -5.667, p \ 0.001) levels as significant
independent variables influencing plasma homocysteine
levels (adjusted R2 = 0.439).
Dietary folate intake
Depending on the residual kidney function, individual
dietary restrictions may be needed in CKD patients.
Patients with decreased eGFR were likely to have super-
vised dietary restrictions. In addition, patients with mod-
erate to severe decreased eGFR tended to take sevelamer
hydrochloride, which interferes with the absorption of
dietary folate [17]. Therefore, dietary folate intake was
examined in 37 patients with eGFR C60 ml/min/1.73 m2,
and valid data were collected from 16 of these patients
(43.2 %). Dietary folate intake was 104–297 lg/day, and
mean dietary folate intake was 196.9 ± 58.0 lg/day. Die-
tary folate intake in 11 of the 16 patients (66.8 %) was
below the RDA for Japanese.
To determine the reasons for dietary folate deficiency,
several clinical features were compared between the PEKT
group (n = 5) and the non-PEKT group (n = 11). No
differences were noted between the two groups for age and
eGFR during the study, time since kidney transplantation,
and energy intake (data not shown). Although no signifi-
cant difference between the two groups was detected,
dietary folate intake in the non-PEKT group (179.7 ±
51.9 lg/day, median 159 lg/day) had a tendency to be
lower than that in the PEKT group (234.7 ± 57.5 lg/day,
median 254 lg/day) (p = 0.157).
Discussion
Hyper-Hcy was prevalent (67.4 %) in adolescents and
young adults who had undergone kidney transplantation
during childhood. Becker-Cohen et al. [18] reported that
58 % (35 of 60) of children and young adult kidney
transplant recipients had hyper-Hcy. Similarly, Belson
et al. [19] showed that 77 % (54 of 70) of pediatric and
young adult kidney transplant recipients had hyper-Hcy.
Therefore, our results are in agreement with these previous
studies [18, 19]. Thus, hyper-Hcy is common in adoles-
cents and young adults who have undergone kidney
transplantation during childhood.
Kidney tissue contains Hcy-metabolizing enzymes such
as methionine synthase and cystathionine b-synthase. High
methionine synthase activity is found in the liver and
kidney, and cystathionine b-synthase expression is detected
in kidney proximal tubular cells [4]. Kidney tissue plays a
role in homocysteine clearance and metabolism [5]. Pre-
vious studies have shown that patients with decreased GFR
are more likely to have hyper-Hcy [6, 19]. Our study
showed that plasma homocysteine levels correlate
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Fig. 3 Relationship between eGFR and plasma homocysteine (Hcy)
levels. Plasma Hcy levels correlate negatively with eGFR (r = -
0.565, p \ 0.01)
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Fig. 4 Relationship between plasma folate levels and plasma homo-
cysteine (Hcy) levels. Plasma Hcy levels correlate negatively with
plasma folate levels (r = -0.434, p \ 0.01)
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negatively with eGFR, which is in agreement with the
results of previous studies [6, 19]. The quality of post-
transplant kidney function correlates significantly with
CVD risk [1]. Thus, our study suggests that preserving
posttransplant residual kidney function has an impact on
improving plasma homocysteine levels and reducing sev-
eral CVD risk.
In addition to kidney dysfunction, homocysteine
metabolism is influenced by plasma folate levels [4]. Our
study showed that 15.7 % of patients (14 of 89) had plasma
folate deficiency. Sakuta et al. [20] reported that gastrec-
tomized patients have a predisposition for plasma folate
deficiency and that the appearance of plasma folate defi-
ciency is higher in gastrectomized patients (12.9 %) com-
pared with healthy subjects (0 %). Given these figures, the
prevalence of folate deficiency in the present study seemed
to be on a par with that of gastrectomized patients.
An inverse association between plasma homocysteine
and plasma folate levels was reported in some previous
studies [4, 10]. Our study showed that plasma homocys-
teine levels correlate negatively with plasma folate levels,
which is in agreement with the results of previous studies
[4, 10]. To examine factors other than eGFR and plasma
folate that influence plasma homocysteine levels, we per-
formed stepwise multiple linear regression analysis.
A priori selected variables included kind of calcineurin
inhibitor, age at kidney transplantation, pretransplant
duration of dialysis, time since transplantation, and age at
examination. Stepwise multiple linear regression analysis
revealed eGFR and plasma folate levels as significant
independent variables influencing plasma homocysteine
levels.
Since dietary folate intake influences plasma folate
levels [21], dietary management of folate is important to
control plasma homocysteine levels after kidney
transplantation.
Brouwer et al. [22] reported that dietary folate from
vegetables and citrus fruits improves plasma folate status
and decreases plasma homocysteine concentrations. In this
study, dietary folate intake in 66.8 % of patients (11 of 16)
was below the RDA for Japanese. Watanabe et al. [23]
reported that dietary folate deficiency is associated with
depression in Japanese women aged 18–29 years and that
the prevalence of dietary folate deficiency (\RDA) was
significantly higher in subjects with depression (75.0 %)
compared with healthy subjects (43.6 %). Although it is
difficult to make a simple comparison of the prevalence of
dietary folate deficiency with this previous study [23], the
prevalence of dietary folate deficiency seems to be high in
the present study.
The reasons for the high number of patients with poor
folate intake in this study are unknown. Vegetables such as
spinach, asparagus, broccoli, and potato and citrus fruits
such as orange are good sources of folate. Patients on
dialysis have limited intake of these foods because of
dietary potassium restrictions. Here, dietary folate intake in
the non-PEKT group had a tendency to be lower than that
in the PEKT group. Given this result, it is speculated that
dietary restrictions, including folate-containing foodstuff
restrictions, in the pretransplant dialysis period were con-
tinued after kidney transplantation in the non-PEKT group.
Although further studies are clearly necessary to verify this
speculation, our results suggest that appropriate dietary
management for adequate dietary folate intake is necessary
for kidney transplant recipients.
Finally, the efficacy of high folate intake for lowering
plasma homocysteine levels in an effort to reduce CVD
risk in kidney transplant recipients remains inconclusive
[4]. A prospective approach is needed to study the effects
of managing dietary folate on CVD morbidity and mor-
tality in adolescents and young adults who have undergone
kidney transplantation during childhood.
Conclusions
Hyper-Hcy and plasma folate deficiency were highly pre-
valent in adolescents and young adults who have under-
gone kidney transplantation during childhood. Moreover,
dietary folate intake in many patients was below the RDA
for Japanese. Taken together, the present findings suggest
that dietary management of folate is necessary for adoles-
cents and young adults who have undergone kidney
transplantation during childhood.
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